Stock AnalizScotts Miracle-gro Co. SMG
Agricultural Chemicals · IPO 1992 · data as of November 13, 2026
Scotts Miracle-gro Co. (SMG) is a industrial company listed in the US with a market value of about $3.7B. In the twelve months to September 30, 2026 it had revenue of $3.3B and net income of $104M, a net margin of 3.2%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (4/5); the weakest is track record (0/5).
Key numbers: a P/E of 19.3, a price to free cash flow of 13.4, 5-year revenue growth of -4% a year, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 51% below the current price.
Score: 1.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- Positive free cash flow
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
- Dividend 3 years in a row
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.4B | $3.6B | $3.6B | $3.9B | $4.9B | $4.1B | $3.2B | $2.7B | $2.6B | $2.5B |
| Net income | $104M | $145M | -$35M | -$380M | -$438M | $512M | $387M | $461M | $64M | $218M | $315M |
| Free cash flow | $278M | $274M | $584M | $438M | -$242M | $165M | $495M | $184M | $274M | $294M | $186M |
| EPS (diluted) | $1.76 | $2.47 | $-0.61 | $-6.79 | $-7.88 | $8.96 | $6.81 | $8.18 | $1.12 | $3.63 | $5.09 |
| Net margin | 3.2% | 4.2% | -1.0% | -10.7% | -11.2% | 10.4% | 9.4% | 14.6% | 2.4% | 8.3% | 12.6% |
| ROIC | — | 11.6% | 7.8% | -5.5% | -10.0% | 15.3% | 18.6% | 12.9% | 6.6% | 13.3% | 14.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 6 analysts is $76.33, 20% above the current price; targets range from $67.00 to $83.00; the consensus rating is “Buy”; expected EPS is $4.79 for the fiscal year ending September 30, 2027.
Frequently asked questions
What is Scotts Miracle-gro’s P/E ratio?
About 19.3, based on the last twelve months of diluted earnings per share (forward P/E about 10.5).
Is Scotts Miracle-gro stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 51% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Scotts Miracle-gro pay a dividend?
Yes. The dividend yield is about 4.06%, and it has paid dividends for 10 years in our data.
Is Scotts Miracle-gro a good stock to buy?
We do not give buy or sell advice. Scotts Miracle-gro scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.